Diego Albrecht

Addition of vildagliptin to insulin improves glycaemic control in type 2 diabetes

Vivian Fonseca, Anja Schweizer, Diego Albrecht et al. · Diabetologia · 2007 · 367 citations · Full text

Metabolic Syndrome, Diabetes Management, Improves Glycaemic Control +9

The effect of sacubitril/valsartan compared to olmesartan on cardiovascular remodelling in subjects with essential hypertension: the results of a randomized, double-blind, active-controlled study

Roland E. Schmieder, Frank Wagner, Michael Mayr et al. · European Heart Journal · 2017 · 155 citations · Full text

Improved Insulin Sensitivity With Angiotensin Receptor Neprilysin Inhibition in Individuals With Obesity and Hypertension

Jens Jordan, Rudi Stinkens, Thomas Jax et al. · Clinical Pharmacology & Therapeutics · 2016 · 120 citations

Pharmacodynamic and Pharmacokinetic Profiles of Sacubitril/Valsartan (<scp>LCZ</scp>696) in Patients with Heart Failure and Reduced Ejection Fraction

Zhanna Kobalava, Yu. V. Kotovskaya, Diego Albrecht et al. · Cardiovascular Therapeutics · 2016 · 79 citations · Full text

Effect of renal function on the pharmacokinetics of LCZ696 (sacubitril/valsartan), an angiotensin receptor neprilysin inhibitor

Surya Ayalasomayajula, Thomas Langenickel, Pierre J. Jordaan et al. · European Journal of Clinical Pharmacology · 2016 · 41 citations

Hypertension, Renal Function, Medicine +5